Published in Infect Genet Evol on August 08, 2009
Beyond the consensus: dissecting within-host viral population diversity of foot-and-mouth disease virus by using next-generation genome sequencing. J Virol (2010) 1.75
Inferring viral quasispecies spectra from 454 pyrosequencing reads. BMC Bioinformatics (2011) 1.62
Genetic heterogeneity of hepatitis C virus in association with antiviral therapy determined by ultra-deep sequencing. PLoS One (2011) 1.39
Reproductive clonality of pathogens: a perspective on pathogenic viruses, bacteria, fungi, and parasitic protozoa. Proc Natl Acad Sci U S A (2012) 1.26
Metagenomic abundance estimation and diagnostic testing on species level. Nucleic Acids Res (2012) 1.11
Dynamics of hepatitis B virus quasispecies in association with nucleos(t)ide analogue treatment determined by ultra-deep sequencing. PLoS One (2012) 1.08
Chronic hepatitis C. Gut Liver (2011) 0.94
Quasispecies of dengue virus. Trop Med Health (2011) 0.89
Genetic analysis of West Nile virus isolates from an outbreak in Idaho, United States, 2006-2007. Int J Environ Res Public Health (2013) 0.87
Thermostability of subpopulations of H2N3 influenza virus isolates from mallard ducks. J Virol (2010) 0.86
Heads or Tails: Genotyping of Hepatitis C Virus Concerning the 2k/1b Circulating Recombinant Form. Int J Mol Sci (2016) 0.81
Innate immunity and hepatitis C virus infection: a microarray's view. Infect Agent Cancer (2012) 0.80
Comparison of quasispecies diversity of HCV between chronic hepatitis c and hepatocellular carcinoma by Ultradeep pyrosequencing. Biomed Res Int (2014) 0.79
Dynamics of defective hepatitis C virus clones in reinfected liver grafts in liver transplant recipients: ultradeep sequencing analysis. J Clin Microbiol (2013) 0.78
Cross-genotypic polyclonal anti-HCV antibodies from human ascitic fluid. J Virol Methods (2010) 0.78
In vitro inhibition of hepatitis C virus by antisense oligonucleotides in PBMC compared to hepatoma cells. Biomed Res Int (2014) 0.76
Influence of host resistance on viral adaptation: hepatitis C virus as a case study. Infect Drug Resist (2015) 0.75
Copy number variation of genes involved in the hepatitis C virus-human interactome. Sci Rep (2016) 0.75
Sendai virus intra-host population dynamics and host immunocompetence influence viral virulence during in vivo passage. Virus Evol (2016) 0.75
Genome sequencing in microfabricated high-density picolitre reactors. Nature (2005) 150.21
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med (2002) 36.55
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet (2001) 35.17
Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics (1989) 19.10
Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A (1991) 14.05
Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. Science (1993) 8.49
The hypercycle. A principle of natural self-organization. Part A: Emergence of the hypercycle. Naturwissenschaften (1977) 7.19
DNA bar coding and pyrosequencing to identify rare HIV drug resistance mutations. Nucleic Acids Res (2007) 6.89
Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature (2005) 6.78
Mutation rates among RNA viruses. Proc Natl Acad Sci U S A (1999) 6.37
Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol (1992) 6.09
Rapid evolution of RNA viruses. Annu Rev Microbiol (1987) 5.97
Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance. Genome Res (2007) 5.95
Viral population estimation using pyrosequencing. PLoS Comput Biol (2008) 5.89
Nucleotide sequence heterogeneity of an RNA phage population. Cell (1978) 5.55
Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir. Gastroenterology (2007) 5.53
Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis (1995) 5.53
The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science (2000) 5.49
RNA virus populations as quasispecies. Curr Top Microbiol Immunol (1992) 5.42
Comparisons of dN/dS are time dependent for closely related bacterial genomes. J Theor Biol (2005) 5.20
PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA. PCR Methods Appl (1991) 4.58
Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes. J Infect Dis (2009) 4.48
Preponderance of synonymous changes as evidence for the neutral theory of molecular evolution. Nature (1977) 4.00
The population genetics of dN/dS. PLoS Genet (2008) 3.88
The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance--a review. Gene (1985) 3.42
Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J Clin Invest (1995) 3.19
Mutation frequencies at defined single codon sites in vesicular stomatitis virus and poliovirus can be increased only slightly by chemical mutagenesis. J Virol (1990) 3.11
Viral quasispecies. Sci Am (1993) 2.91
Variability of hepatitis C virus. Hepatology (1995) 2.90
Natural prevalence of hepatitis C virus variants with decreased sensitivity to NS3.4A protease inhibitors in treatment-naive subjects. J Infect Dis (2008) 2.69
Viral error catastrophe by mutagenic nucleosides. Annu Rev Microbiol (2004) 2.58
Error thresholds and the constraints to RNA virus evolution. Trends Microbiol (2003) 2.42
'Cold SSCP': a simple, rapid and non-radioactive method for optimized single-strand conformation polymorphism analyses. Nucleic Acids Res (1993) 2.38
Evolution of envelope sequences from the genital tract and peripheral blood of women infected with clade A human immunodeficiency virus type 1. J Virol (1998) 2.21
Viruses as quasispecies: biological implications. Curr Top Microbiol Immunol (2006) 2.21
Lack of evidence for proofreading mechanisms associated with an RNA virus polymerase. Gene (1992) 2.20
Divergent and convergent evolution after a common-source outbreak of hepatitis C virus. J Exp Med (2005) 2.16
How sensitive is PCR-SSCP? Hum Mutat (1993) 2.13
RNA virus quasispecies populations can suppress vastly superior mutant progeny. J Virol (1990) 2.12
RNA virus quasispecies: significance for viral disease and epidemiology. Infect Agents Dis (1994) 2.08
Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J Virol (2002) 2.05
Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome. Proc Natl Acad Sci U S A (2002) 2.04
Quasispecies theory in the context of population genetics. BMC Evol Biol (2005) 2.02
Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinemic patient. Gastroenterology (1994) 2.00
Extreme heterogeneity in populations of vesicular stomatitis virus. J Virol (1989) 1.95
New observations on antigenic diversification of RNA viruses. Antigenic variation is not dependent on immune selection. J Gen Virol (1993) 1.87
The error threshold. Virus Res (2005) 1.84
The evolution of RNA viruses: A population genetics view. Proc Natl Acad Sci U S A (2000) 1.84
Human immunodeficiency virus type 1 quasispecies in vivo and ex vivo. Curr Top Microbiol Immunol (1992) 1.77
On the nature of virus quasispecies. Trends Microbiol (1996) 1.73
Relative replication capacity and selective advantage profiles of protease inhibitor-resistant hepatitis C virus (HCV) NS3 protease mutants in the HCV genotype 1b replicon system. Antimicrob Agents Chemother (2007) 1.59
Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations. J Virol (1998) 1.59
Quasispecies made simple. PLoS Comput Biol (2005) 1.56
Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin. Lancet (1995) 1.54
Foot-and-mouth disease virus populations are quasispecies. Curr Top Microbiol Immunol (1992) 1.53
Tracking changes in HIV-1 envelope quasispecies using DNA heteroduplex analysis. Methods (1997) 1.50
Is the quasispecies concept relevant to RNA viruses? J Virol (2002) 1.48
Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection. J Virol (1998) 1.46
Curing of foot-and-mouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis. Virology (2003) 1.44
Nonrandom distribution of hepatitis C virus quasispecies in plasma and peripheral blood mononuclear cell subsets. J Virol (1999) 1.42
Frequent compartmentalization of hepatitis C virus variants in circulating B cells and monocytes. Hepatology (2004) 1.41
Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells. J Virol (2005) 1.41
Quasispecies dynamics and RNA virus extinction. Virus Res (2005) 1.35
Degree of diversity of hepatitis C virus quasispecies and progression of liver disease. Hepatology (1994) 1.35
Evidence for the non-quasispecies evolution of RNA viruses [corrected]. Mol Biol Evol (2001) 1.31
Genetic diversity and tissue compartmentalization of the hepatitis C virus genome in blood mononuclear cells, liver, and serum from chronic hepatitis C patients. J Virol (1998) 1.31
Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients. J Virol (1996) 1.31
Quasispecies heterogeneity within the E1/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection. J Virol (2005) 1.29
Hepatitis C virus quasispecies in patients infected with HIV-1: correlation with extrahepatic viral replication. Virology (1998) 1.27
Evolution of the hepatitis C virus second envelope protein hypervariable region in chronically infected patients receiving alpha interferon therapy. J Virol (1999) 1.26
Competitive selection in vivo by a cell for one variant over another: implications for RNA virus quasispecies in vivo. J Virol (1996) 1.26
The '30K' superfamily of viral movement proteins. J Gen Virol (2000) 1.26
Distinct repertoire of antigenic variants of foot-and-mouth disease virus in the presence or absence of immune selection. J Virol (1993) 1.26
Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C. J Med Virol (1998) 1.25
A unique, predominant hepatitis C virus variant found in an infant born to a mother with multiple variants. J Virol (1993) 1.23
Nucleotide and amino acid complexity of hepatitis C virus quasispecies in serum and liver. J Virol (2000) 1.23
Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment. Hepatology (1995) 1.22
Differential distribution and internal translation efficiency of hepatitis C virus quasispecies present in dendritic and liver cells. Blood (2002) 1.19
Quasispecies and its impact on viral hepatitis. Virus Res (2007) 1.19
Molecular and bioinformatic evidence of hepatitis C virus evolution in brain. J Infect Dis (2008) 1.18
Sequence analysis of the hepatitis C virus genome recovered from serum, liver, and peripheral blood mononuclear cells of infected chimpanzees. J Virol (1997) 1.17
Quasispecies in viral persistence and pathogenesis of hepatitis C virus. Trends Microbiol (1999) 1.13
Characterization of simple and complex hepatitis C virus quasispecies by heteroduplex gel shift analysis: correlation with nucleotide sequencing. J Gen Virol (1995) 1.13
Evolution of hepatitis C viral quasispecies and hepatic injury in perinatally infected children followed prospectively. Proc Natl Acad Sci U S A (2006) 1.11
Wide range of quasispecies diversity during primary hepatitis C virus infection. J Virol (2005) 1.10
New concepts for dealing with the evolution of nucleic acids. Cold Spring Harb Symp Quant Biol (1987) 1.10
Mutations within the E2 and NS5A protein in patients infected with hepatitis C virus type 3a and correlation with treatment response. Hepatology (2000) 1.10
Immunity in chimpanzees chronically infected with hepatitis C virus: role of minor quasispecies in reinfection. J Virol (1998) 1.09
Assessment of hepatitis C virus quasispecies heterogeneity by gel shift analysis: correlation with response to interferon therapy. J Infect Dis (1997) 1.09
HCV quasispecies evolution: association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV. Blood (2004) 1.08
Hepatitis C viral quasispecies in hepatitis C virus carriers with normal liver enzymes and patients with type C chronic liver disease. Hepatology (1995) 1.08
Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b infection [correction of interferon]. Hepatology (1999) 1.08
Clinical implications of viral quasispecies heterogeneity in chronic hepatitis C. J Med Virol (1996) 1.06
Dynamic behavior of hepatitis C virus in chronically infected patients receiving liver graft from infected donors. Virology (1996) 1.06
Effect of immunosuppression on composition of quasispecies population of hepatitis C virus in patients with chronic hepatitis C coinfected with human immunodeficiency virus. J Hepatol (1997) 1.05
Associations among clinical, immunological, and viral quasispecies measurements in advanced chronic hepatitis C. Hepatology (2005) 1.05
Detection of hepatitis C virus sequences in brain tissue obtained in recurrent hepatitis C after liver transplantation. Liver Transpl (2002) 1.04
The nature of interferon-alpha resistance in hepatitis C virus infection. Curr Opin Infect Dis (2003) 1.04
Rare birds in North America: acute hepatitis C cohorts. Gastroenterology (2008) 3.45
A cis-acting replication element in the sequence encoding the NS5B RNA-dependent RNA polymerase is required for hepatitis C virus RNA replication. J Virol (2004) 2.36
Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites. Hepatology (2006) 2.08
Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men: a prospective cohort study. J Infect Dis (2008) 1.78
Evidence for a functional RNA element in the hepatitis C virus core gene. Proc Natl Acad Sci U S A (2007) 1.64
Accelerated hepatitis C virus kinetics but similar survival rates in recipients of liver grafts from living versus deceased donors. Hepatology (2005) 1.44
Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir-based triple therapy. Liver Int (2013) 1.43
Molecular and bioinformatic evidence of hepatitis C virus evolution in brain. J Infect Dis (2008) 1.18
Mutation Master: profiles of substitutions in hepatitis C virus RNA of the core, alternate reading frame, and NS2 coding regions. RNA (2002) 1.13
Short communication: Inadequate vitamin D exacerbates parathyroid hormone elevations in tenofovir users. AIDS Res Hum Retroviruses (2010) 1.08
Clinicopathologic correlates of hepatitis C virus in brain: a pilot study. J Neurovirol (2008) 1.08
Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response. Hepatology (2014) 1.05
Internal initiation stimulates production of p8 minicore, a member of a newly discovered family of hepatitis C virus core protein isoforms. J Virol (2009) 1.01
Increased prooxidant production and enhanced susceptibility to glutathione depletion in HepG2 cells co-expressing HCV core protein and CYP2E1. J Med Virol (2004) 0.99
Mutations in the hepatitis C virus core gene are associated with advanced liver disease and hepatocellular carcinoma. Clin Cancer Res (2009) 0.99
Classical and emerging roles of vitamin D in hepatitis C virus infection. Semin Liver Dis (2011) 0.94
Adipocyte accumulation of long-chain fatty acids in obesity is multifactorial, resulting from increased fatty acid uptake and decreased activity of genes involved in fat utilization. Obes Surg (2009) 0.93
Telaprevir in the treatment of acute hepatitis C virus infection in HIV-infected men. Clin Infect Dis (2013) 0.90
Evaluation of fatigue in U.S. patients with primary biliary cirrhosis. Am J Gastroenterol (2005) 0.89
Vitamin D for your patients with chronic hepatitis C? J Hepatol (2012) 0.89
Rapid progression to decompensated cirrhosis, liver transplant, and death in HIV-infected men after primary hepatitis C virus infection. Clin Infect Dis (2012) 0.88
Early-onset liver fibrosis due to primary hepatitis C virus infection is higher over time in HIV-infected men. Clin Infect Dis (2012) 0.82
Insulin resistance predicts re-treatment failure in an efficacy study of peginterferon-α-2a and ribavirin in HIV/HCV co-infected patients. J Hepatol (2010) 0.82
Correlates of hypertension in patients with AIDS in the era of highly active antiretroviral therapy. J Int Assoc Provid AIDS Care (2013) 0.82
HCV and HCC: clinical update and a review of HCC-associated viral mutations in the core gene. Semin Liver Dis (2011) 0.82
Cross-genotypic polyclonal anti-HCV antibodies from human ascitic fluid. J Virol Methods (2010) 0.78
Recurrence of primary biliary cirrhosis and development of autoimmune hepatitis after liver transplant: A blind histologic study. Hepatol Res (2009) 0.75